Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001171843-14-003162
Filing Date
2014-07-07
Accepted
2014-07-07 14:26:28
Documents
4
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A f20fa_070714.htm 20-F/A 77572
2 EXHIBIT 4.13 exh_413.htm EX-4.13 367856
3 EXHIBIT 12.1 exh_121.htm EX-12.1 20248
4 EXHIBIT 12.2 exh_122.htm EX-12.2 20338
  Complete submission text file 0001171843-14-003162.txt   486965
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 20-F/A | Act: 34 | File No.: 001-35773 | Film No.: 14962793
SIC: 2834 Pharmaceutical Preparations